MICHELE YORK to Parkinson Disease
This is a "connection" page, showing publications MICHELE YORK has written about Parkinson Disease.
Connection Strength
5.818
-
A Patient's Guide to Memory Changes in Parkinson Disease. Arch Phys Med Rehabil. 2024 03; 105(3):615-619.
Score: 0.484
-
Enough vs. More: Neuropsychological testing is more useful than genetic testing in the baseline evaluation of Parkinson disease. Parkinsonism Relat Disord. 2023 06; 111:105403.
Score: 0.482
-
Development of standardized regression-based formulas to assess meaningful cognitive change in early Parkinson's disease. Arch Clin Neuropsychol. 2021 Jul 19; 36(5):734-745.
Score: 0.425
-
The global pandemic has permanently changed the state of practice for pre-DBS neuropsychological evaluations. Parkinsonism Relat Disord. 2021 05; 86:135-138.
Score: 0.420
-
A validation of a self-administered screening test for Parkinson's disease. J Neurol Sci. 2020 Nov 15; 418:117116.
Score: 0.400
-
Performance Validity in Deep Brain Stimulation Candidates. Arch Clin Neuropsychol. 2018 Jun 01; 33(4):508-514.
Score: 0.342
-
Comparative Patient Satisfaction and Feasibility of a Pilot Parkinson's Disease Enrichment Program. J Geriatr Psychiatry Neurol. 2017 Sep; 30(5):253-260.
Score: 0.325
-
Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31.
Score: 0.226
-
Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7.
Score: 0.211
-
Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7.
Score: 0.206
-
Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71.
Score: 0.187
-
Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8.
Score: 0.171
-
Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95.
Score: 0.164
-
Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866.
Score: 0.161
-
Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example. Mov Disord. 2025 Mar; 40(3):468-477.
Score: 0.135
-
Long-Term Dementia Risk in Parkinson Disease. Neurology. 2024 09 10; 103(5):e209699.
Score: 0.131
-
Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. J Parkinsons Dis. 2024; 14(1):135-166.
Score: 0.126
-
Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21.
Score: 0.118
-
Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease. Parkinsonism Relat Disord. 2022 02; 95:23-27.
Score: 0.109
-
North American survey on impact of the COVID-19 pandemic shutdown on DBS care. Parkinsonism Relat Disord. 2021 11; 92:41-45.
Score: 0.108
-
Pallidotomy and psychological outcomes. J Neurosurg. 2001 May; 94(5):866-8.
Score: 0.105
-
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461.
Score: 0.097
-
Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020 01; 70:96-102.
Score: 0.095
-
Neuropsychological outcome following unilateral pallidotomy. Brain. 1999 Dec; 122 ( Pt 12):2209-20.
Score: 0.095
-
Acute and Long-Term Effects of Multidirectional Treadmill Training on Gait and Balance in Parkinson Disease. PM R. 2016 12; 8(12):1151-1158.
Score: 0.074
-
A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
Score: 0.070
-
Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9.
Score: 0.066
-
Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014; 4(4):591-8.
Score: 0.063
-
Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May; 18(4):377-81.
Score: 0.055
-
Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
Score: 0.055
-
Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
Score: 0.042
-
Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36.
Score: 0.025
-
Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients. Neurology. 1998 Feb; 50(2):434-8.
Score: 0.021
-
The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8.
Score: 0.013
-
The neural substrates of reward processing in humans: the modern role of FMRI. Neuroscientist. 2004 Jun; 10(3):260-8.
Score: 0.008